A safe contraceptive method for women of reproductive age with obesity
Г.У. СултанмуратоваTashkent medical academy, Tashkent, UzbekistanГ.С. БабаджановаTashkent medical academy, Tashkent, UzbekistanЖ.Б. НазарбаевUrgench branch of Tashkent medical academy, Urgench, UzbekistanН.М. КеримоваUrgench branch of Tashkent medical academy, Urgench, Uzbekistan
ABI
Abstract
Aim. The purpose of this study is to determine the safety of using a drospirenone-containing combinedoral contraceptive (СOC) in overweight/obese women of reproductive age.Material and methods. The study included 65 women of reproductive age who were prescribed OC with30 µg of ethinyl estradiol and 3 mg of drospirenone for 3 months for therapeutic and preventive purposes.The main parameters evaluated were lipid and carbohydrate metabolism.Results. According to the results of the study, a favorable effect of low-dose COCs on body weight and lipidprofile was revealed without significant changes in carbohydrate metabolism.Conclusion. СOC may be recommended for overweight/obese patients to control fertility in the postpartum period.
Topics
Identifiers
Citations and references
Cited by 00 references
Metrics — AkademScholar · Coming soon